Nucleic Acid Therapeutics CDMO Market Size, Share & Trends Analysis Report By Therapy / Modality Type (mRNA-based Therapeutics, DNA / Plasmid DNA Therapeutics, siRNA (Small Interfering RNA), Antisense Oligonucleotides (ASOs), Gene Therapy Products, Others), By Service Type (Process Development & Optimization, Drug Product (Formulation, Fill & Finish), Analytical & Quality Control (QC) Services, Regulatory Support & Technology Transfer, Packaging & Fill–Finish Services), By Workflow Stage (Preclinical Development, Clinical Manufacturing (Phase I–III), Commercial-Scale Production), By End User, By Therapeutic Area, By Region and By Segments Forecasts, 2025-2034